Management of Controlled Diabetes with Elevated Anion Gap

Diagnostic Approach

The American College of Physicians recommends immediate identification of the underlying cause of an elevated anion gap of 17 in a patient with controlled diabetes through targeted laboratory evaluation, as this represents moderate metabolic acidosis requiring prompt investigation even when glucose control appears adequate 1
The American Diabetes Association suggests obtaining arterial or venous blood gas to assess pH and bicarbonate levels, with venous pH being acceptable and typically 0.03 units lower than arterial 1
The American Association of Clinical Endocrinologists recommends measuring serum and urine ketones, specifically beta-hydroxybutyrate, to evaluate for diabetic ketoacidosis 1, 3
Plasma glucose should be measured to confirm current glycemic status, according to the American Diabetes Association 1, 2
A complete metabolic panel, including electrolytes, BUN, and creatinine, should be obtained to assess renal function, as recommended by the National Kidney Foundation 1, 2
Serum lactate should be measured to evaluate for lactic acidosis, according to the American College of Emergency Physicians 2
Serum osmolality with calculated osmolar gap should be measured if toxic ingestion is suspected, as recommended by the American Association of Poison Control Centers 2

The American Diabetes Association notes that an anion gap of 17 in a diabetic patient most commonly indicates diabetic ketoacidosis, even with "controlled" glucose, particularly in patients on SGLT2 inhibitors 1, 3
Lactic acidosis from tissue hypoperfusion or medication effects should be considered as a potential cause of an elevated anion gap, according to the American College of Clinical Pharmacology 3
Uremic acidosis from renal dysfunction is another possible cause of an elevated anion gap, as noted by the National Kidney Foundation 3
Starvation ketosis can occur even in diabetics with relatively normal glucose, according to the American Diabetes Association 3

If the patient is taking an SGLT2 inhibitor, euglycemic ketoacidosis must be strongly suspected, as these medications predispose to ketoacidosis even with glucose levels <200 mg/dL, according to the American Association of Clinical Endocrinologists 3
The American College of Physicians recommends monitoring closely with repeat electrolytes, glucose, and venous pH every 2-4 hours if pH >7.3 and bicarbonate ≥18 mEq/L 1
Identifying and treating the underlying cause, such as discontinuing SGLT2 inhibitors, addressing dehydration, and treating infection, is crucial, according to the American Diabetes Association 1, 3
No bicarbonate therapy is needed at a pH level >7.3, as recommended by the American College of Emergency Physicians 1, 2
If pH 7.0-7.3 or bicarbonate <18 mEq/L, aggressive treatment should be initiated, including fluid resuscitation, continuous IV regular insulin, and potassium replacement, according to the American Association of Clinical Endocrinologists 1, 2
If pH <7.0, consideration of sodium bicarbonate administration and all other aggressive measures should be taken, as recommended by the American College of Emergency Physicians 1, 2

The American Diabetes Association recommends tracking anion gap normalization to ≤12 mEq/L, glucose <200 mg/dL, serum bicarbonate ≥18 mEq/L, and venous pH >7.3 every 2-4 hours until stabilized 1
The anion gap provides the most reliable marker of treatment response, as it reflects total unmeasured anion burden regardless of specific ketone species, according to the American Association of Clinical Endocrinologists 1
If the patient is on an SGLT2 inhibitor, this medication should be discontinued immediately, as cessation is associated with reduced risk of high anion gap acidosis, according to the American Association of Clinical Endocrinologists 3